{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:17:39Z","timestamp":1789186659243,"version":"build-2803163510"},"reference-count":29,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","award":["[2021-164"],"award-info":[{"award-number":["[2021-164"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.1080\/14740338.2023.2284989","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:20:17Z","timestamp":1700205617000},"page":"917-923","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Newly identified adverse events for gemcitabine using the Food and Drug Administration Adverse Event Reporting System"],"prefix":"10.1080","volume":"23","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanxi Medical Service Evaluation Center, Department of health management, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiye","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chang","sequence":"additional","affiliation":[{"name":"Shanxi Provincial Hospital of Traditional Chinese Medicine, Department of Physician Standardization Training Center, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,20]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/jo00246a002"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2403"},{"issue":"4","key":"e_1_3_7_5_1","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett W","year":"1995","unstructured":"Plunkett W, Huang P, Xu YZ, et al. Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol. 1995 Aug;22(4 Suppl 11):3\u201310.","journal-title":"Semin Oncol"},{"key":"e_1_3_7_6_1","first-page":"1","article-title":"A real-world data analysis of topotecan in the FDA adverse event Reporting system (FAERS) database","volume":"30","author":"Yang H","year":"2023","unstructured":"Yang H, Wan Z, Chen M, et al. A real-world data analysis of topotecan in the FDA adverse event Reporting system (FAERS) database. Expert Opin Drug Metab Toxicol. 2023 May;30:1\u20137.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-200202000-00021"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X18809268"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl507"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001785"},{"key":"e_1_3_7_11_1","first-page":"1","article-title":"Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database","volume":"11","author":"Chow JW","year":"2022","unstructured":"Chow JW, Yan MM, Zhao H, et al. Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database. Expert Opin Drug Saf. 2022 Nov;11:1\u20139.","journal-title":"Expert Opin Drug Saf"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1001"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.1999.10474456"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000471"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2016.06.002"},{"issue":"26","key":"e_1_3_7_18_1","first-page":"1744","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Eaton JM","year":"1996","unstructured":"Eaton JM. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Jun 27;334(26):1744\u20131745. author reply 1746.","journal-title":"N Engl J Med"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00111-8"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-11-1332"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005850"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0730-725X(01)00217-X"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860410018494"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro1045"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2009.41.1.53"},{"issue":"9","key":"e_1_3_7_26_1","first-page":"611","article-title":"Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature","volume":"10","author":"Truong QV","year":"2012","unstructured":"Truong QV, Abraham J, Nagaiah G, et al. Gemcitabine associated with posterior reversible encephalopathy syndrome (PRES): a case report and review of the literature. Clin Adv Hematol Oncol. 2012 Sep;10(9):611\u2013613.","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324581"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0980-2"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2972-3"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0873-9"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2012.09.008"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2284989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:46:29Z","timestamp":1727279189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2284989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,20]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1080\/14740338.2023.2284989"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2284989","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}